[{"address1": "219 Terry Ave. N", "address2": "Suite 300", "city": "Seattle", "state": "WA", "zip": "98109", "country": "United States", "phone": "206 378 0400", "website": "https://kinetabio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Seattle, Washington.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig W. Philips", "age": 62, "title": "President", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": 485787, "exercisedValue": 0, "unexercisedValue": 8582}, {"maxAge": 1, "name": "Ms. Pauline  Kenny Esq., J.D.", "age": 49, "title": "Advisor", "yearBorn": 1974, "fiscalYear": 2022, "totalPay": 349716, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Keith A. Baker", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thierry  Guillaudeux Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Gary  Gentges", "title": "Executive Vice President of Corporate Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.62, "open": 0.6094, "dayLow": 0.57, "dayHigh": 0.65, "regularMarketPreviousClose": 0.62, "regularMarketOpen": 0.6094, "regularMarketDayLow": 0.57, "regularMarketDayHigh": 0.65, "forwardPE": -0.47392592, "volume": 182404, "regularMarketVolume": 182404, "averageVolume": 378720, "averageVolume10days": 932040, "averageDailyVolume10Day": 932040, "bid": 0.5971, "ask": 0.6457, "bidSize": 500, "askSize": 500, "marketCap": 7013807, "fiftyTwoWeekLow": 0.334, "fiftyTwoWeekHigh": 5.39, "priceToSalesTrailing12Months": 1.288829, "fiftyDayAverage": 0.9795, "twoHundredDayAverage": 2.462185, "currency": "USD", "enterpriseValue": 2716782, "profitMargins": -2.59078, "floatShares": 6588110, "sharesOutstanding": 10962500, "sharesShort": 95121, "sharesShortPriorMonth": 75256, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0087, "heldPercentInsiders": 0.2925, "heldPercentInstitutions": 0.1205, "shortRatio": 0.21, "shortPercentOfFloat": 0.012200001, "impliedSharesOutstanding": 10962500, "bookValue": 0.278, "priceToBook": 2.3014388, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -14099000, "trailingEps": -1.28, "forwardEps": -1.35, "lastSplitFactor": "1:7", "lastSplitDate": 1671408000, "enterpriseToRevenue": 0.499, "enterpriseToEbitda": -0.173, "52WeekChange": -0.83879095, "SandP52WeekChange": 0.21080327, "lastDividendValue": 10.01, "lastDividendDate": 1671408000, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "KA", "underlyingSymbol": "KA", "shortName": "Kineta, Inc.", "longName": "Kineta, Inc.", "firstTradeDateEpochUtc": 1455201000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "709960ac-3b08-3407-99b9-a14d0009bc3c", "messageBoardId": "finmb_83494411", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.6398, "targetHighPrice": 13.5, "targetLowPrice": 13.5, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 5783000, "totalCashPerShare": 0.528, "ebitda": -15714000, "totalDebt": 1317000, "quickRatio": 0.818, "currentRatio": 0.845, "totalRevenue": 5442000, "debtToEquity": 43.053, "revenuePerShare": 0.492, "returnOnAssets": -0.70911, "returnOnEquity": -3.69013, "freeCashflow": -10421500, "operatingCashflow": -16209000, "revenueGrowth": -1.0, "grossMargins": -0.65803003, "ebitdaMargins": -2.8875399, "operatingMargins": -2.8892002, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-26"}]